ReviewBriefings in bioinformatics2026
Artificial intelligence-enabled multi-scale virtual cell: perspective, challenges, and opportunities.
Review in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
As the fundamental unit of life, cells coordinate biological activities through the interaction between microscopic molecular mechanisms and macroscopic tissue organization. Traditional research studies, experiments, and biochemical analyses, give rise to important insights, although they are restricted in spatiotemporal resolution and processing power, thereby precluding the understanding of dynamic cross-scale biological events . Breakthroughs in artificial intelligence (AI) have given birth to the AI virtual cell (AIVC) as a new way to do research. By integrating multi-omics data and mixing methods from multidisciplinary models, AIVC establishes a digital twin system to simulate cell functions and behaviors. AIVC still faces a number of pressing challenges that need to be addressed in its current development stage. In this review, we are proposing a unified definition and technical framework for AIVC and analyze in detail the cross-scale coupling mechanisms of the "gene-protein-pathway-cell" hierarchy. Furthermore, we decompose the technical construction framework of AIVC from cross-scale representation engineering, functional submodule design, and multi-component dynamic regulation mechanisms. Additionally, we summarize the existing models and datasets in the field to provide reference resources for researchers. Finally, we deeply discuss the challenges faced by AIVC, such as data heterogeneity and model interpretability, and aim to accelerate the research progress in the AIVC field while driving the life sciences to shift from observational analysis to a paradigm that integrates predictability and innovation. Despite being in the early stage, AIVC is a trending topic that has garnered widespread interest. This review aims to integrate existing models, datasets, and technical ideas to provide a unified framework for field development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.